Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies

E-ISSN： 1873-4316|12|6|923-930

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.6, 2011-06, pp. : 923-930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 6, 2011-06 ,pp. : 861-866

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogren's Syndrome

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. : 10-19

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging strategies for treatment of venous thromboembolism

By Prandoni Paolo

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 87-94

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the treatment of myelodysplastic syndrome

By Nivatpumin Philip J Gore Steven D

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 569-590

Informa Healthcare

Access to resources Recommend Favorite

Idursulfase for the treatment of mucopolysaccharidosis II

By Clarke Lorne A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite